Product Program year 2020 Source: CMS Open Payments

Exparel

Drug Pain Management

NDC 65250-266-20

Open in the dashboard

General payments

$10,511,902

14,772 payments

Research payments

$10,026,447

470 payments

Through program year 2020, $10,511,902 in general payments and $10,026,447 in research payments were reported against Exparel (Pain Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $3,256,182 3,909
2020 Research $5,612,548 221
2019 General $7,255,720 10,863
2019 Research $4,413,899 249

Breakdown

Who paid General payments · program years 2019–2020
  1. Pacira Pharmaceuticals Incorporated $10,511,902 14,772 payments
Top recipients General payments · program year 2020
  1. Mark Froimson Orthopaedic Surgery · Cleveland, OH $468,517 14% · 13 payments
  2. Mark Kronenfeld Anesthesiology · Brooklyn, NY $441,613 14% · 6 payments
  3. Gabriel Mena Anesthesiology · Houston, TX $196,366 6% · 8 payments
  4. Jeffrey Gonzales Anesthesiology · Aurora, CO $154,992 5% · 52 payments
  5. Darin Rentz Anesthesiology · Lakewood, CO $123,843 4% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Anesthesiology $1,773,115 59% · 890 practitioners
  2. Orthopaedic Surgery $635,326 21% · 316 practitioners
  3. Internal Medicine $199,922 7% · 8 practitioners
  4. Adult Reconstructive Orthopaedic Surgery Orthopaedic Surgery $88,243 3% · 21 practitioners
  5. Pain Medicine Anesthesiology $56,776 2% · 44 practitioners

The top 5 of 87 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. New York $700,747 22% · 72 recipients
  2. Ohio $583,915 18% · 84 recipients
  3. Texas $457,122 14% · 392 recipients
  4. North Carolina $284,972 9% · 51 recipients
  5. Colorado $281,563 9% · 71 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

14,772 general · 470 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record